Barinthus Biotherapeutics plc (BRNS) Misses Q2 EPS by 16c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q2 EPS of ($0.52), $0.16 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Marlin Business Services (MRLN) Reports Q2 Loss of $1.40